Drug Treatment of Benign Prostatic Hyperplasia and Hospital Admission for BPH-Related Surgery

By Souverein P.C.   Erkens J.A.   de la Rosette J.J.M.C.H.   Leufkens H.G.M.   Herings R.M.C.  

European Urology, Vol. 43, Iss. 5, 2003-05 ,pp. : 528-534

Elsevier

Access to resources Recommend Favorite

Long-term 6-year experience with finasteride in patients with benign prostatic hyperplasia

By Lowe F.C.   McConnell J.D.   Hudson P.B.   Romas N.A.   Boake R.   Lieber M.   Elhilali M.   Geller J.   Imperto-McGinely J.   Andriole G.L.   Bruskewitz R.C.   Walsh P.C.   Bartsch G.   Nacey J.N.   Shah S.   Pappas F.   Ko A.   Cook T.   Stoner E.   Waldstreicher J.   FINASTERIDE STUDY GROUP  

Urology, Vol. 61, Iss. 4, 2003-04 ,pp. : 791-796

Elsevier

Access to resources Recommend Favorite

Phase III Multicenter Placebo-Controlled Study of Tamsulosin in Benign Prostatic Hyperplasia - a randomized, controlled trial in patients with benign prostatic 'obstruction' (symptomatic BPH)

By Lepor H.  

Urology, Vol. 51, Iss. 6, 1998-06 ,pp. : 892-900

Elsevier

Access to resources Recommend Favorite

Achieving the Total Approach in Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia (LUTS/BPH) Management

By O'Leary M.  

European Urology Supplements, Vol. 2, Iss. 7, 2003-11 ,pp. : 25-33

Elsevier

Access to resources Recommend Favorite

The Total Approach in Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia (LUTS/BPH) Management: Introduction and Conclusions

By Chapple C.R.  

European Urology Supplements, Vol. 2, Iss. 7, 2003-11 ,pp. : 1-5

Elsevier

Access to resources Recommend Favorite